
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $723.5M | $769.6M | $784.6M | $839.2M | $995.6M | |
Revenue Growth (YoY) | 7.84% | 6.38% | 1.95% | 6.97% | 18.63% | |
Cost of Revenues | $109.4M | $113.9M | $135.4M | $151.6M | $179M | |
Gross Profit | $614.1M | $655.7M | $649.2M | $687.6M | $816.6M | |
Gross Profit Margin | 84.88% | 85.21% | 82.74% | 81.94% | 82.02% | |
R&D Expenses | $133.4M | $153.6M | $141.8M | $132.3M | $146.3M | |
Selling, General & Admin | $424.2M | $444.7M | $445M | $469M | $572.5M | |
Other Inc / (Exp) | -$64.2M | -$4.9M | -$69.2M | -$1.3M | -$13.9M | |
Operating Expenses | $572.2M | $608M | $596.1M | $607.7M | $727.9M | |
Operating Income | $41.9M | $47.8M | $53M | $79.9M | $88.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$21.2M | $43.4M | -$15.4M | $83.6M | $81.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9.7M | $9.8M | $20.4M | -$85.3M | $4.9M | |
Net Income to Company | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Basic EPS (Cont. Ops) | -$0.66 | $0.74 | -$0.80 | $3.85 | $1.74 | |
Diluted EPS (Cont. Ops) | -$0.66 | $0.71 | -$0.80 | $3.75 | $1.68 | |
Weighted Average Basic Share | $46.7M | $45.4M | $44.7M | $43.9M | $43.9M | |
Weighted Average Diluted Share | $46.7M | $47.2M | $44.7M | $45.1M | $45.2M | |
EBITDA | -$5.4M | $54.5M | -$4.6M | $90.6M | $90.7M | |
EBIT | -$21.2M | $43.5M | -$14.9M | $84M | $81.5M | |
Revenue (Reported) | $723.5M | $769.6M | $784.6M | $839.2M | $995.6M | |
Operating Income (Reported) | $41.9M | $47.8M | $53M | $79.9M | $88.7M | |
Operating Income (Adjusted) | -$21.2M | $43.5M | -$14.9M | $84M | $81.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $191.3M | $205.9M | $203.5M | $223.3M | $275M | |
Revenue Growth (YoY) | 16.14% | 7.64% | -1.2% | 9.74% | 23.18% | |
Cost of Revenues | $29.6M | $32M | $34.8M | $39.1M | $47.8M | |
Gross Profit | $161.7M | $173.9M | $168.7M | $184.1M | $227.3M | |
Gross Profit Margin | 84.53% | 84.44% | 82.9% | 82.47% | 82.63% | |
R&D Expenses | $35.6M | $40.5M | $32.2M | $35.2M | $39.3M | |
Selling, General & Admin | $109.9M | $115.3M | $115M | $124.4M | $158.4M | |
Other Inc / (Exp) | -$3.8M | -$3.4M | -$57.8M | -$1.5M | $67K | |
Operating Expenses | $147.6M | $158.3M | $148.8M | $161.4M | $200.2M | |
Operating Income | $14.1M | $15.6M | $19.9M | $22.7M | $27.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $10.6M | $12.2M | -$37.6M | $23.1M | $28.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.3M | $4.2M | $5.9M | -$103.1M | -$2.4M | |
Net Income to Company | $6.3M | $8M | -$43.5M | $126.1M | $31M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $6.3M | $8M | -$43.5M | $126.1M | $31M | |
Basic EPS (Cont. Ops) | $0.13 | $0.18 | -$0.98 | $2.89 | $0.70 | |
Diluted EPS (Cont. Ops) | $0.13 | $0.17 | -$0.98 | $2.81 | $0.69 | |
Weighted Average Basic Share | $46.9M | $44.6M | $44.4M | $43.7M | $44.1M | |
Weighted Average Diluted Share | $46.9M | $46.2M | $44.4M | $45.3M | $45.2M | |
EBITDA | $13.1M | $15.2M | -$35.8M | $25M | $31.2M | |
EBIT | $10.6M | $12.3M | -$37.5M | $23.2M | $28.7M | |
Revenue (Reported) | $191.3M | $205.9M | $203.5M | $223.3M | $275M | |
Operating Income (Reported) | $14.1M | $15.6M | $19.9M | $22.7M | $27.1M | |
Operating Income (Adjusted) | $10.6M | $12.3M | -$37.5M | $23.2M | $28.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $723.5M | $769.6M | $784.6M | $839.2M | $995.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $109.4M | $113.9M | $135.4M | $151.6M | $179M | |
Gross Profit | $614.1M | $655.7M | $649.2M | $687.6M | $816.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $133.4M | $153.6M | $141.8M | $132.3M | $146.3M | |
Selling, General & Admin | $424.2M | $444.7M | $445M | $469M | $572.5M | |
Other Inc / (Exp) | -$64.2M | -$4.9M | -$69.2M | -$1.3M | -$13.9M | |
Operating Expenses | $572.2M | $608M | $596.1M | $607.7M | $727.9M | |
Operating Income | $41.9M | $47.8M | $53M | $79.9M | $88.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$21.2M | $43.4M | -$15.4M | $83.6M | $81.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9.7M | $9.8M | $20.4M | -$85.3M | $4.9M | |
Net Income to Company | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Basic EPS (Cont. Ops) | -$0.67 | $0.74 | -$0.81 | $3.87 | $1.73 | |
Diluted EPS (Cont. Ops) | -$0.68 | $0.71 | -$0.81 | $3.76 | $1.69 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $42.8M | $54.5M | -$4.6M | $90.6M | $90.7M | |
EBIT | $27M | $43.5M | -$14.9M | $84M | $81.5M | |
Revenue (Reported) | $723.5M | $769.6M | $784.6M | $839.2M | $995.6M | |
Operating Income (Reported) | $41.9M | $47.8M | $53M | $79.9M | $88.7M | |
Operating Income (Adjusted) | $27M | $43.5M | -$14.9M | $84M | $81.5M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $769.6M | $784.6M | $839.2M | $995.6M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $113.9M | $135.4M | $151.6M | $179M | -- | |
Gross Profit | $655.7M | $649.2M | $687.6M | $816.6M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $153.6M | $141.8M | $132.3M | $146.3M | -- | |
Selling, General & Admin | $444.7M | $445M | $469M | $572.5M | -- | |
Other Inc / (Exp) | -$4.9M | -$69.2M | -$1.3M | -$13.9M | -- | |
Operating Expenses | $608M | $596.1M | $607.7M | $727.9M | -- | |
Operating Income | $47.8M | $53M | $79.9M | $88.7M | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $43.4M | -$15.4M | $83.6M | $81.1M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9.8M | $20.4M | -$85.3M | $4.9M | -- | |
Net Income to Company | $33.6M | -$35.8M | $168.9M | $76.1M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $33.6M | -$35.8M | $168.9M | $76.1M | -- | |
Basic EPS (Cont. Ops) | $0.74 | -$0.81 | $3.87 | $1.73 | -- | |
Diluted EPS (Cont. Ops) | $0.71 | -$0.81 | $3.76 | $1.69 | -- | |
Weighted Average Basic Share | $181.8M | $178.7M | $175.5M | $175.4M | -- | |
Weighted Average Diluted Share | $188.7M | $180.6M | $180M | $180.5M | -- | |
EBITDA | $54.5M | -$4.6M | $90.6M | $90.7M | -- | |
EBIT | $43.5M | -$14.9M | $84M | $81.5M | -- | |
Revenue (Reported) | $769.6M | $784.6M | $839.2M | $995.6M | -- | |
Operating Income (Reported) | $47.8M | $53M | $79.9M | $88.7M | -- | |
Operating Income (Adjusted) | $43.5M | -$14.9M | $84M | $81.5M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $188.1M | $194.2M | $210.4M | $222.7M | $252M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $22.2M | $22.3M | $14M | $21M | $46.2M | |
Total Current Assets | $607.6M | $484.1M | $550.9M | $595.1M | $635.1M | |
Property Plant And Equipment | $133.6M | $121.4M | $20.1M | $18.5M | $18.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $112.4M | $127.8M | $127.8M | $127.8M | $185.3M | |
Other Intangibles | -- | $3.5M | $2.3M | $1M | $20.7M | |
Other Long-Term Assets | $12.1M | $26.3M | $21.9M | $27.4M | $46.1M | |
Total Assets | $904.2M | $816.1M | $782.6M | $943.9M | $1.1B | |
Accounts Payable | $374K | $432K | $108K | $299K | $373K | |
Accrued Expenses | $42.3M | $48.4M | $39.8M | $46.3M | $52.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7.5M | $4.8M | $4.5M | $4.9M | $4.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $373.2M | $394.1M | $410.1M | $484.9M | $555.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $510.1M | $560.3M | $596.5M | $665.8M | $793.1M | |
Common Stock | $463K | $443K | $440K | $435K | $441K | |
Other Common Equity Adj | -$10.4M | -$11.9M | -$16.1M | -$15.9M | -$15.6M | |
Common Equity | $394M | $255.8M | $186.1M | $278.1M | $325.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $394M | $255.8M | $186.1M | $278.1M | $325.1M | |
Total Liabilities and Equity | $904.2M | $816.1M | $782.6M | $943.9M | $1.1B | |
Cash and Short Terms | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $188.1M | $194.2M | $210.4M | $222.7M | $252M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $22.2M | $22.3M | $14M | $21M | $46.2M | |
Total Current Assets | $607.6M | $484.1M | $550.9M | $595.1M | $635.1M | |
Property Plant And Equipment | $133.6M | $121.4M | $20.1M | $18.5M | $18.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $112.4M | $127.8M | $127.8M | $127.8M | $185.3M | |
Other Intangibles | -- | $3.5M | $2.3M | $1M | $20.7M | |
Other Long-Term Assets | $12.1M | $26.3M | $21.9M | $27.4M | $46.1M | |
Total Assets | $904.2M | $816.1M | $782.6M | $943.9M | $1.1B | |
Accounts Payable | $374K | $432K | $108K | $299K | $373K | |
Accrued Expenses | $42.3M | $48.4M | $39.8M | $46.3M | $52.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7.5M | $4.8M | $4.5M | $4.9M | $4.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $373.2M | $394.1M | $410.1M | $484.9M | $555.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $510.1M | $560.3M | $596.5M | $665.8M | $793.1M | |
Common Stock | $463K | $443K | $440K | $435K | $441K | |
Other Common Equity Adj | -$10.4M | -$11.9M | -$16.1M | -$15.9M | -$15.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $394M | $255.8M | $186.1M | $278.1M | $325.1M | |
Total Liabilities and Equity | $904.2M | $816.1M | $782.6M | $943.9M | $1.1B | |
Cash and Short Terms | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Depreciation & Amoritzation | $15.9M | $11M | $10.3M | $6.5M | $9.2M | |
Stock-Based Compensation | $84.8M | $105.2M | $105.7M | $94.6M | $113.3M | |
Change in Accounts Receivable | -$34.6M | -$20.4M | -$11.6M | -$21.7M | -$62M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $124M | $177.2M | $170.3M | $203.8M | $207.4M | |
Capital Expenditures | $8.2M | $3.9M | $3.2M | $4.1M | $3.8M | |
Cash Acquisitions | -- | -$16.9M | -- | -- | -$65.3M | |
Cash From Investing | $35.5M | -$24.4M | -$5.3M | -$5.5M | -$70.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$95.3M | -$305.2M | -$150.9M | -$184M | -$165M | |
Other Financing Activities | -- | -$609K | -$63K | -- | -$340K | |
Cash From Financing | -$74.7M | -$276.1M | -$135.6M | -$170.6M | -$147.8M | |
Beginning Cash (CF) | $296.1M | $397.2M | $267.5M | $287.8M | $312.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $84.7M | -$123.4M | $29.4M | $27.7M | -$10.8M | |
Ending Cash (CF) | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Levered Free Cash Flow | $115.8M | $173.3M | $167M | $199.7M | $203.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.3M | $8M | -$43.5M | $126.1M | $31M | |
Depreciation & Amoritzation | $2.5M | $2.9M | $1.7M | $1.8M | $2.4M | |
Stock-Based Compensation | $23.3M | $28.4M | $24.7M | $22.6M | $29M | |
Change in Accounts Receivable | $4.3M | $5.2M | $6.2M | -$1M | $3.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $64.7M | $87.1M | $67.8M | $80M | $77M | |
Capital Expenditures | $2.2M | $583K | $1.1M | $859K | $783K | |
Cash Acquisitions | -- | -- | -- | -- | $598K | |
Cash From Investing | $8.7M | -$18.1M | -$1.1M | -$1.2M | -$730K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$62.1M | -$39.8M | -$60.8M | -$50.4M | -$29.8M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$48.6M | -$33.8M | -$54.7M | -$44.7M | -$23.7M | |
Beginning Cash (CF) | $377.6M | $233.7M | $273.5M | $284.3M | $243.6M | |
Foreign Exchange Rate Adjustment | -$5.1M | -$1.5M | $2.3M | -$5.6M | $6M | |
Additions / Reductions | $24.8M | $35.3M | $12M | $34.1M | $52.5M | |
Ending Cash (CF) | $397.2M | $267.5M | $287.8M | $312.8M | $302.1M | |
Levered Free Cash Flow | $62.5M | $86.5M | $66.8M | $79.1M | $76.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$31M | $33.6M | -$35.8M | $168.9M | $76.1M | |
Depreciation & Amoritzation | $15.9M | $11M | $10.3M | $6.5M | $9.2M | |
Stock-Based Compensation | $84.8M | $105.2M | $105.7M | $94.6M | $113.3M | |
Change in Accounts Receivable | -$34.6M | -$20.4M | -$11.6M | -$21.7M | -$62M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $124M | $177.2M | $170.3M | $203.8M | $207.4M | |
Capital Expenditures | $8.2M | $3.9M | $3.2M | $4.1M | $3.8M | |
Cash Acquisitions | -- | -- | -- | -- | -$65.3M | |
Cash From Investing | $35.5M | -$24.4M | -$5.3M | -$5.5M | -$70.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$95.3M | -$305.2M | -$150.9M | -$184M | -$165M | |
Other Financing Activities | -- | -- | -$63K | -- | -- | |
Cash From Financing | -$74.7M | -$276.1M | -$135.6M | -$170.6M | -$147.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $84.7M | -$123.4M | $29.4M | $27.7M | -$10.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $115.8M | $173.3M | $167M | $199.7M | $203.6M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $33.6M | -$35.8M | $168.9M | $76.1M | -- | |
Depreciation & Amoritzation | $11M | $10.3M | $6.5M | $9.2M | -- | |
Stock-Based Compensation | $105.2M | $105.7M | $94.6M | $113.3M | -- | |
Change in Accounts Receivable | -$20.4M | -$11.6M | -$21.7M | -$62M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $177.2M | $170.3M | $203.8M | $207.4M | -- | |
Capital Expenditures | $3.9M | $3.2M | $4.1M | $3.8M | -- | |
Cash Acquisitions | -- | -- | -- | -$65.3M | -- | |
Cash From Investing | -$24.4M | -$5.3M | -$5.5M | -$70.4M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$305.2M | -$150.9M | -$184M | -$165M | -- | |
Other Financing Activities | -$609K | -$63K | -- | -- | -- | |
Cash From Financing | -$276.1M | -$135.6M | -$170.6M | -$147.8M | -- | |
Beginning Cash (CF) | $1.3B | $1.1B | $1.1B | $1.1B | -- | |
Foreign Exchange Rate Adjustment | -$6.4M | -$9.2M | -$2.7M | $185K | -- | |
Additions / Reductions | -$123.4M | $29.4M | $27.7M | -$10.8M | -- | |
Ending Cash (CF) | $1.2B | $1.1B | $1.2B | $1.1B | -- | |
Levered Free Cash Flow | $173.3M | $167M | $199.7M | $203.6M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.